Predicting the development of diabetic nephropathy and its progression

Josette William, Donn Hogan, Daniel Batlle*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Diabetes remains the number one cause of end-stage renal disease worldwide. Only about one third of diabetic patients develop nephropathy, and the risk appears to be, in part, genetically determined. In this article, we review clinical and genetic markers for the development and progression of diabetic nephropathy. Microalbuminuria remains the best available predictor of the subsequent development of nephropathy, even though in recent years it has become clear that less than 50% of individuals with type 1 diabetes progress to overt proteinuria over a period of less than 10 years. It is of great interest for early recognition of risk of nephropathy that small elevations in nighttime blood pressure predict microalbuminuria in type 1 diabetes. Genetic markers for diabetic nephropathy have not been conclusively identified. The occurrence of renal events in diabetic patients, however, appears to be influenced by the angiotensin-converting enzyme (ACE) genotype, with a dominant deleterious effect of the D allele (D/D or I/D) versus I/I genotype. Some patients with the DD genotype also appear less susceptible to the renoprotective effects of conventional doses of ACE inhibitors, suggesting that ACE genotyping might be useful in selecting those patients that could benefit from higher doses of ACE inhibitors and more aggressive treatment to prevent or delay disease progression.

Original languageEnglish (US)
Pages (from-to)202-211
Number of pages10
JournalAdvances in Chronic Kidney Disease
Volume12
Issue number2
DOIs
StatePublished - Jan 1 2005

Keywords

  • ACE gene polymorphisms
  • ACE inhibitors
  • Diabetic nephropathy
  • Nocturnal Hypertension
  • Proteinuria

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Predicting the development of diabetic nephropathy and its progression'. Together they form a unique fingerprint.

Cite this